Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IFOSFAMIDE vs ILOPROST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IFOSFAMIDE vs ILOPROST: Safety Overview

Metric IFOSFAMIDE ILOPROST
Total FAERS Reports 17,004 4,961
Deaths Reported 3,365 2,277
Death Rate 19.8% 45.9%
Hospitalizations 5,230 2,324
Average Patient Age 36.2 yrs 57.9 yrs
% Female Patients 41.7% 70.7%
FDA Approval Date Apr 4, 2007 Aug 7, 2009
Manufacturer Baxter Healthcare Corporation BTG International Inc
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Discontinued